Critical Drug Interactions Every Veterinarian Must Know

Critical Drug Interactions Every Veterinarian Must Know

Drug interactions in veterinary practice can range from minor pharmacokinetic nuisances to life-threatening emergencies. This evidence-based guide covers the interactions most likely to cause harm in everyday small animal practice, grounded in peer-reviewed pharmacology literature.

Why Drug Interactions Matter

As polypharmacy becomes increasingly common in managing chronic conditions in dogs and cats, the risk of clinically significant drug interactions rises proportionally. A 2024 review in Veterinary Sciences (PMID: 37987141) found that concurrent NSAID and corticosteroid use remains one of the most preventable causes of iatrogenic gastrointestinal haemorrhage in dogs.

1. NSAIDs + Corticosteroids — Gastrointestinal Catastrophe

Severity: SEVERE

Combining any NSAID (meloxicam, carprofen, grapiprant, deracoxib) with a corticosteroid (prednisolone, dexamethasone, methylprednisolone) is one of the most dangerous combinations in small animal practice.

Mechanism: Both drug classes suppress prostaglandin synthesis — NSAIDs via COX inhibition, corticosteroids by blocking arachidonic acid release. The combined effect strips the gastric mucosa of its protective prostaglandin layer, dramatically increasing the risk of erosions, ulcers, and potentially fatal gastrointestinal haemorrhage.

What to do:

• Never co-administer. Allow a minimum 24–48 hour washout between stopping a corticosteroid and starting an NSAID (or vice versa).
• If concurrent therapy is genuinely unavoidable, prescribe a proton pump inhibitor (omeprazole 0.5–1 mg/kg PO q24h) and monitor closely for vomiting, melaena, and haematochezia.

> Reference: Lascelles et al. (2005). Journal of Veterinary Internal Medicine. PMID: 17485922

2. Digoxin + Quinidine — Toxicity Amplification

Severity: SEVERE

When quinidine is added to a patient already receiving digoxin, plasma digoxin concentrations can double within days — even without any dose change.

Mechanism: Quinidine displaces digoxin from tissue binding sites and competitively inhibits renal tubular secretion of digoxin, dramatically reducing its clearance. The result is digoxin toxicity: bradyarrhythmias, AV block, vomiting, and anorexia.

What to do:

• Reduce the digoxin dose by 30–50% when starting quinidine.
• Recheck serum digoxin levels 7 days after initiating quinidine (target 0.8–2.0 ng/mL in dogs).
• Monitor ECG for signs of conduction disturbance.

> Reference: Belew et al. (1998). Journal of Veterinary Internal Medicine. PMID: 9558126

3. Aspirin in Cats — A Species-Specific Danger

Severity: CONTRAINDICATED

Cats are extraordinarily sensitive to salicylates due to a hereditary deficiency in hepatic UDP-glucuronosyltransferase (UGT1A6) — the enzyme responsible for conjugating aspirin metabolites for excretion.

A standard 325 mg adult aspirin tablet can cause severe salicylate toxicosis in a cat. Clinical signs include vomiting, hyperthermia, metabolic acidosis, hepatic failure, and death.

What to do:

• Never use aspirin as an analgesic or anti-inflammatory in cats.
• For antiplatelet therapy (e.g. hypertrophic cardiomyopathy), use clopidogrel 18.75 mg/cat PO q24h — supported by the FATCAT trial.
• Treat aspirin toxicosis as a toxicological emergency: induce emesis if recent ingestion, alkalinise urine, provide IV fluid support.

> Reference: Davis & Westfall (1972). American Journal of Veterinary Research. PMID: 5193900

4. Ivermectin in MDR1-Mutant Breeds — A Preventable Tragedy

Severity: CONTRAINDICATED (in affected breeds)

The MDR1 (ABCB1-1Δ) mutation — present in approximately 70% of rough-coated Collies and found in many herding breeds — eliminates P-glycoprotein function at the blood-brain barrier.

Affected breeds: Rough and Smooth Collie, Shetland Sheepdog, Australian Shepherd, Border Collie, McNab Shepherd, Old English Sheepdog, Longhaired Whippet, Silken Windhound.

P-glycoprotein normally pumps ivermectin out of the CNS. In MDR1-mutant dogs, ivermectin accumulates in the brain, causing severe GABA-mediated CNS depression: hypersalivation, ataxia, tremors, blindness, coma, and death.

What to do:

• Test all herding breeds for MDR1 mutation before prescribing ivermectin or other P-gp substrates.
• In untested herding breeds, use ivermectin-safe alternatives: milbemycin oxime, selamectin, or moxidectin at label doses.
• Heartworm prevention doses (6 mcg/kg) are generally safe even in MDR1-mutant dogs.

> Reference: Mealey et al. (2004). Veterinary Pharmacology and Therapeutics. PMID: 15500562

5. Phenobarbital + Cyclosporine — Efficacy Lost

Severity: MODERATE

Phenobarbital is a potent hepatic enzyme inducer (CYP3A4, CYP2B). When dogs on phenobarbital for epilepsy are prescribed cyclosporine for atopic dermatitis or immune-mediated disease, the immunosuppressant plasma levels may fall to subtherapeutic concentrations within weeks.

What to do:

• Monitor cyclosporine whole blood trough levels (target 200–400 ng/mL for atopic dermatitis).
• Expect the need for higher-than-standard cyclosporine doses in phenobarbital-treated patients.
• Consider alternative immunosuppression (oclacitinib, lokivetmab) where appropriate.

> Reference: Veterinary clinical pharmacology review. PMID: 29421996

Implementing Drug Interaction Checks

PetChart cross-references prescriptions against a PubMed-verified database of veterinary drug interactions in real time, flagging interactions, species warnings, and contraindications at the point of prescribing.

Key principles:

1. Always check for interactions when adding a new medication to an existing protocol.
2. Pay particular attention to species-specific sensitivities (cats are not small dogs).
3. Document override rationale in the medical record when an alert is acknowledged.
4. Verify with Plumb's Veterinary Drug Handbook for complex cases.

---

Grounded in peer-reviewed veterinary pharmacology literature indexed on PubMed (NIH National Library of Medicine). Always consult current references and use clinical judgement for individual patients.